Skip to main content

Advertisement

Log in

Hydroxyapatite–collagen augments osteogenic differentiation of dental pulp stem cells

  • Original Article
  • Published:
Odontology Aims and scope Submit manuscript

Abstract

The objectives of this study were to isolate and culture dental pulp stem cells (DPSCs) and to investigate their proliferation and osteogenic differentiation on hydroxyapatite–collagen (HA–Col) scaffold. DPSCs were characterized by fluorescence-activated cell sorting (FACS). Cultured cells were CD73+, CD90+, CD105+ and CD31, CD45. A commercially available HA–Col scaffold was used for culture of DPSCs. Cell attachment and viability of DPSCs cultured on scaffold was studied by sulforhodamine assay. Osteoblast differentiation capacity was studied by alkaline phosphatase assay and the effects of growth factors such as PDGF, IGF1 and FGF2 were further studied. Scanning electron microscopy (SEM) of cell seeded scaffolds was also performed. We found that DPSCs cultured exhibited the characteristic mesenchymal stem cells (MSCs) morphology and differentiation properties. Scaffold was found to be non-cytotoxic and had good biocompatibility in vitro. Osteoblast differentiation ability was found to increase at higher concentration of scaffold and additive effects were observed with the use of growth factors. In SEM, cells appeared to cover the entire surface of the scaffold forming continuous cell layer and extending filopodial extensions. HA–Col scaffold is apt for MSCs attachment and proliferation in vitro. Their unique self-renewal and multilineage differential potential make them ideal for use in regenerative medicine. The limitations of currently available bone graft materials have led to the emergence of tissue engineering using mesenchymal stem cells (MSCs). Since, HA–Col scaffold potentiated the proliferation and osteogenic differentiation of DPSCs, this biomimetic material may be an ideal one for maxillofacial and alveolar bone regeneration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Chen Q, Shou P, Zheng C, et al. Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? Cell Death Differ. 2016;23(7):1128.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kfoury Y, Scadden DT. Mesenchymal cell contributions to the stem cell niche. Cell Stem Cell. 2015;16(3):239–53.

    Article  PubMed  Google Scholar 

  3. Kassem M, Abdallah BM. Human bone-marrow-derived mesenchymal stem cells: biological characteristics and potential role in therapy of degenerative diseases. Cell Tissue Res. 2008;331(1):157–63.

    Article  PubMed  Google Scholar 

  4. Kim HJ, Park JS. Usage of human mesenchymal stem cells in cell-based therapy: advantages and disadvantages. Dev Reprod. 2017;21(1):1.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Garba A, Desmarets LM, Acar DD, et al. Immortalized porcine mesenchymal cells derived from nasal mucosa, lungs, lymph nodes, spleen and bone marrow retain their stemness properties and trigger the expression of siglec-1 in co-cultured blood monocytic cells. PLoS One. 2017;12(10):e0186343.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Nuti N, Corallo C, Chan BM, et al. Multipotent differentiation of human dental pulp stem cells: a literature review. Stem Cell Rev Rep. 2016;12(5):511–23.

    Article  PubMed  Google Scholar 

  7. Potdar PD, Jethmalani YD. Human dental pulp stem cells: applications in future regenerative medicine. World J Stem Cells. 2015;7(5):839.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006;1(3):1112–6.

    Article  PubMed  Google Scholar 

  9. Yang M, Arai A, Udagawa N, et al. Parathyroid hormone shifts cell fate of a leptin receptor-marked stromal population from adipogenic to osteoblastic lineage. J Bone Miner Res. 2019. https://doi.org/10.1002/jbmr.3811.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Gautam AK, Bhargavan B, Tyagi AM, et al. Differential effects of formononetin and cladrin on osteoblast function, peak bone mass achievement and bioavailability in rats. J Nutr Biochem. 2011;22(4):318–27.

    Article  PubMed  Google Scholar 

  11. Fotakis G, Timbrell JA. In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol Lett. 2006;160(2):171–7.

    Article  PubMed  Google Scholar 

  12. Reible B, Schmidmaier G, Moghaddam A, et al. Insulin like growth factor-1 as a possible alternative to bone morphogenetic protein-7 to induce osteogenic differentiation on human mesenchymal stem cells in vitro. Int J Mol Sci. 2018;19(6):1674.

    Article  PubMed Central  Google Scholar 

  13. Khan Y, Yaszemski MJ, Mikos AG, et al. Tissue engineering of bone: material and matrix considerations. J Bone Jt Surg. 2008;90:36–42.

    Article  Google Scholar 

  14. Sancilio S, Gallorini M, Di Nisio C et al. Alginate/hydroxyapatite-based nanocomposite scaffolds for bone tissue engineering improve dental pulp biomineralization and differentiation. Stem Cells Int. 2018;2018:9643721. https://doi.org/10.1155/2018/9643721.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Masuda HT, Ishihara S, Harada I, et al. Coating extracellular matrix proteins on a (3-aminopropyl) triethoxysilanetreated glass substrate for improved cell culture. Biotechniques. 2014;56(4):172–9.

    Article  PubMed  Google Scholar 

  16. van den Dolder J, Jansen JA. The response of osteoblast-like cells towards collagen type I coating immobilized by p-nitrophenyl chloroformate to titanium. J Biomed Mater Res A. 2007;83(3):712–9.

    Article  PubMed  Google Scholar 

  17. Vandrovcová MA, Douglas TI, Hauk DO, et al. Influence of collagen and chondroitin sulfate (CS) coatings on poly-(lactide-co-glycolide) (PLGA) on MG 63 osteoblast-like cells. Physiol Res. 2011;60(5):797–813.

    Article  PubMed  Google Scholar 

  18. Zhang Y, Reddy VJ, Wong SY, et al. Enhanced biomineralization in osteoblasts on a novel electrospun biocomposite nanofibrous substrate of hydroxyapatite/collagen/chitosan. Tissue Eng Part A. 2010;16(6):1949–60.

    Article  PubMed  Google Scholar 

  19. Antebi B, Cheng X, Harris JN, et al. Biomimetic collagen–hydroxyapatite composite fabricated via a novel perfusion-flow mineralization technique. Tissue Eng Part C Methods. 2013;19(7):487–96.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Ning L, Malmström H, Ren YF. Porous collagen–hydroxyapatite scaffolds with mesenchymal stem cells for bone regeneration. J Oral Implantol. 2015;41(1):45–9.

    Article  PubMed  Google Scholar 

  21. Atari M, Caballé-Serrano J, Gil-Recio C, et al. The enhancement of osteogenesis through the use of dental pulp pluripotent stem cells in 3D. Bone. 2012;50(4):930–41.

    Article  PubMed  Google Scholar 

  22. Kashef-Saberi MS, Roodbari NH, Parivar K, et al. Enhanced osteogenic differentiation of mesenchymal stem cells on electrospun polyethersulfone/poly(vinyl) alcohol/platelet rich plasma nanofibrous scaffold. ASAIO J. 2018;4(5):e115–22.

    Article  Google Scholar 

  23. Li A, Xia X, Yeh J, et al. PDGF-AA promotes osteogenic differentiation and migration of mesenchymal stem cell by down-regulating PDGFRα and derepressing BMP-Smad 1/5/8 signaling. PLoS One. 2014;9(12):e113785.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Kumar A, Salimath BP, Stark GB, et al. Platelet derived growth factor receptor signaling is not involved in osteogenic differentiation of human mesenchymal stem cells. Tissue Eng Part A. 2010;16(3):983–93.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank Dr. Prabhaker Mishra, Department of Biostatistics and Health Informatics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, for providing assistance in statistical analysis. This project was partially funded by the Department of Health Research, New Delhi, India (DHR-MRU 014).

Funding

No funding.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Divya Mehrotra or Satyendra Kumar Singh.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 20 kb)

10266_2019_464_MOESM2_ESM.pdf

Supplementary material 2 Supplementary Fig. 1. After 10 days of osteogenic differentiation concentration of RANKL was determined by ELISA in cell lysate of DPMSCs grown with or without HA–collagen scaffold. Data are presented as mean ± SEM (n = 2). RANKL, Receptor Activator of Nuclear Factor Kappa. (PDF 5 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Trivedi, S., Srivastava, K., Saluja, T.S. et al. Hydroxyapatite–collagen augments osteogenic differentiation of dental pulp stem cells. Odontology 108, 251–259 (2020). https://doi.org/10.1007/s10266-019-00464-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10266-019-00464-0

Keywords

Navigation